Richard B Parad MD MPH
Birth Defect Genetics, Neonatal Respiratory Failure & Lung Development
Director, Newborn Genomic Medicine Program, Department of Pediatric Newborn Medicine, Brigham and Women's Hospital
Join to View Full Profile
75 Francis St Cwn 418Brigham & Women's HospitalBoston, MA 02115
Phone+1 617-732-7371
Fax+1 617-278-6983
Dr. Parad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Richard Parad is a neonatologist in Boston, MA and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital, Boston Children's Hospital, Beth Israel Deaconess Medical Center, Massachusetts General Hospital, and Newton-Wellesley Hospital. He received his medical degree from University of California San Diego School of Medicine and has been in practice 36 years. He specializes in birth defect genetics and neonatal respiratory failure & lung development.
Education & Training
Harvard School of Public HealthMPH, Quantitative Methods, 1994 - 1997
Boston Children’s Hospital/Boston Medical CenterFellowship, Neonatal-Perinatal Medicine, 1984 - 1987- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1981 - 1984
University of California San Diego School of MedicineClass of 1981
Certifications & Licensure
ME State Medical License Current
MA State Medical License 1984 - 2027
FL State Medical License 1993 - 2012
American Board of Pediatrics Pediatrics- American Board of Pediatrics Neonatal-Perinatal Medicine
Clinical Trials
- Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome Start of enrollment: 2013 Oct 01
- Genomic Sequencing for Childhood Risk and Newborn Illness Start of enrollment: 2015 May 01
Publications & Presentations
PubMed
- Interpreting Neonatal hyperCKemia Identified Through Duchenne Muscular Dystrophy Newborn Screening: A Predictive Model Based on Maternal, Labor, Delivery and Newborn F...Elisa N Falk, Stephen M Chrzanowski, Francesca Coyne, Yvonne Sheldon, Sara Cherkerzian
Muscle & Nerve. 2026-03-01 - Operationalizing the Wilson-Jungner principles for the genomics era: Consensus recommendations from the International Consortium on Newborn Sequencing.Lilian Downie, Julie Yeo, Thomas Minten, Rose Heald, Derek Ansel
Genetics in Medicine. 2026-01-01 - Expansion of variant panels in newborn screening algorithms to identify cystic fibrosis: A retrospective analysis of 25 years of genotypes and implications on diagnosis.Jaime E Hale, Brian P O'Sullivan, Richard B Parad, Henry L Dorkin, Ted M Kremer
Genetics in Medicine. 2026-01-01
Press Mentions
Cureduchenne Launches Innovative Supplemental Newborn Screening Initiative Offering Opportunity for Early Diagnosis of Rare, Fatal DiseaseJuly 22nd, 2021- Brigham and Women's Hospital Partners with CureDuchenne on Newborn Screening ProgramJuly 22nd, 2021
Increase in Genetic Testing Brings Decrease in Some Hereditary DiseasesFebruary 24th, 2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
